Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
---|
07/07/1992 | US5128327 Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle |
06/30/1992 | US5126452 Optically active stereoisomers |
06/30/1992 | US5126347 Autoimmune deficiency syndrome |
06/30/1992 | US5126345 Viricides |
06/30/1992 | CA1304365C Oxetanocins |
06/25/1992 | WO1992010497A1 ENANTIOMERICALLY PURE β-D-(-)-DIOXOLANE-NUCLEOSIDES |
06/25/1992 | WO1992010496A1 ENANTIOMERICALLY PURE β-L-(-)-1,3-OXATHIOLANE NUCLEOSIDES |
06/25/1992 | CA2590125A1 Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
06/24/1992 | EP0490967A1 Process for preparing 3,7-dialkyl xanthines |
06/24/1992 | CN1062138A Synergism of hiv reverse transcriptase inhibitors |
06/24/1992 | CN1017153B Purine-substituted oxygen heterocycle butane |
06/22/1992 | WO1992011260A1 Xanthine derivatives |
06/22/1992 | CA2098846A1 Xanthine derivatives |
06/21/1992 | CA2055129A1 Cam-lock busway joint assembly |
06/17/1992 | EP0490181A1 Use of xanthines for preparation of a medicament having immunosuppressing activity |
06/17/1992 | EP0489876A1 Synthesis of cyclopentene derivatives |
06/17/1992 | CN1061972A Process for preparing hydroxymethyl (methylenecyclopentyl) purines and pyrimidines |
06/11/1992 | WO1992009604A1 6-azido-2-fluoropurine |
06/09/1992 | US5120747 Platelet activating factor antagonists |
06/09/1992 | US5120740 Targeting antitumor drugs to kidneys |
06/09/1992 | CA1303037C Purinone derivatives as bronchodilators vasodilators and anti-allergic agents |
06/03/1992 | EP0488345A1 1,4-Dihydropyridine derivatives and methods of producing the same |
06/03/1992 | EP0488079A1 Oxadiazolylmethylpurines, their preparation, and their pharmaceutical use |
06/03/1992 | EP0487694A1 Oligonucleotide functionalization method |
06/03/1992 | EP0487673A1 New xanthine derivatives |
06/03/1992 | EP0487658A1 Synthesis of purine substituted cyclopentene derivatives |
06/03/1992 | EP0487657A1 Process for the synthesis of cyclopentene derivatives |
06/03/1992 | CN1061600A Chemical process |
06/02/1992 | US5118808 Pharmaceutical preparations |
06/02/1992 | US5118689 Antiarrhythmia agents |
06/02/1992 | US5118500 Side effect reduction when administering a xanthine derivative |
06/02/1992 | CA1302410C Dihydropyridine anti-allergic and anti-inflammatory agents |
05/31/1992 | CA2056800A1 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans |
05/31/1992 | CA2056723A1 Use of xanthines for the preparation of a medicament having immuno supressing activity |
05/29/1992 | WO1992008717A1 Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
05/26/1992 | CA1301755C Process for recovering caffeine adsorbed to activated carbon |
05/26/1992 | CA1301754C Process for recovering caffeine absorbed in activated carbon, and a process for decaffeinating coffee |
05/23/1992 | CA2055946A1 Chemical process |
05/22/1992 | WO1992009203A1 Tnf inhibitors |
05/22/1992 | CA2096623A1 Tnf inhibitors |
05/14/1992 | WO1992007852A1 Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders |
05/13/1992 | EP0485156A1 Methods and compounds for labeling DNA with xanthine and lower alkyl substituted xanthine derivatives and reagents for the in situ detection of chromosomes |
05/13/1992 | EP0484785A2 Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses |
05/12/1992 | US5112844 Micelles |
05/12/1992 | CA1300622C Anti-viral compounds |
05/08/1992 | CA2055041A1 Use of xanthines for the preparation of a medicament effective for inhibiting the replication of human retroviruses |
05/06/1992 | EP0484071A2 Synergism of HIV reverse transcriptase inhibitors |
05/06/1992 | EP0483985A1 Fungicides |
05/06/1992 | CN1060842A Cyelobutane derivatives |
05/05/1992 | US5110929 Quaternization of pyrazine compounds |
05/05/1992 | US5110926 Carbocyclic guanosine |
05/05/1992 | US5110818 Antiepileptic agents |
05/02/1992 | CA2054529A1 Synergism of hiv reverse transcriptase inhibitors |
04/29/1992 | EP0482493A2 Pharmaceutical compositions active in the therapy of neurological affections in aids patients, containing as an active principle at last one compound selected from the group consisting of S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid, 5-formyltetrahydrofolic acid |
04/28/1992 | US5109003 Method for the treatment of peptic ulcer disease |
04/23/1992 | DE4031601A1 New bi:phenyl:methyl-substd. imidazole derivs. |
04/22/1992 | EP0481754A2 Hydroxymethyl(methylenecyclopentyl)Purines and Pyrimidines |
04/22/1992 | EP0481320A1 Novel cyclobutane derivatives |
04/19/1992 | WO1992006976A1 Xanthine derivative |
04/18/1992 | WO1992006977A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
04/18/1992 | CA2071911A1 P-substituted derivatives of phenyl 4-oxybutane amine, processes for preparation thereof, and pharmaceutical compositions holding same |
04/16/1992 | WO1992006086A1 Novel 4-piperidinylcarbonyl derivatives |
04/15/1992 | EP0480659A2 Use of Angiotensin-II antagonists for the manufacture of a medicament for the treatment of hyperuricemia |
04/15/1992 | EP0480204A1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor |
04/15/1992 | EP0479822A1 Therapeutic nucleosides |
04/14/1992 | USRE33887 Anti-retroviral compounds |
04/14/1992 | US5104443 Heterocyclic 2-alkoxyphenoxysulfonylureas and the use thereof as herbicides or plant growth regulators |
04/10/1992 | CA2052315A1 Cyclobutane derivatives |
04/08/1992 | EP0478628A1 Pyrrol derivates, their preparation and their use as interceptors of activated dioxygen |
04/07/1992 | US5102880 Biphenyl imidazotriazine derivatives; Hypotensive and cardiotonic agents |
04/07/1992 | US5102443 Heterocyclically substituted phenoxysulfonylureas, and the use thereof as herbicides or plant growth regulators |
04/03/1992 | WO1992006102A1 Nucleoside derivatives |
04/03/1992 | CA2093020A1 Nucleoside derivatives |
04/02/1992 | WO1992005180A1 Heterocyclic compounds |
04/02/1992 | WO1992005177A1 Compounds having antihypertensive and anti-ischemic properties |
04/01/1992 | EP0477700A1 6'-C-alkyl- or alkynyl-neplanocin A, and its preparation process and use |
04/01/1992 | CN1059909A Carbocyclic adenosine analogs useful as immunosuppressants |
03/27/1992 | WO1992005176A1 Xanthines |
03/27/1992 | WO1992005175A1 Xanthine derivatives |
03/27/1992 | CA2092430A1 Xanthine derivatives |
03/27/1992 | CA2092429A1 Xanthines |
03/26/1992 | CA2052125A1 Heterocyclic derivatives |
03/24/1992 | US5098996 Process for introducing fluorine into biologically active materials |
03/24/1992 | US5098906 Autoimmune disease treatment, antiinflammatory agents and viricides |
03/24/1992 | US5098805 Nondiscoloring photographic films |
03/18/1992 | EP0475413A2 Carbocyclic nucleoside analogs useful as immunosuppressants |
03/18/1992 | EP0475411A1 Novel carbocyclic adenosine analogs useful as immunosuppressants |
03/18/1992 | CN1059528A Carbocyclic analogs of certain nucleosides |
03/18/1992 | CN1059524A Nucleic acid derivatives |
03/17/1992 | US5097097 Triazinylaminofluoresceins |
03/11/1992 | WO1992004321A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity |
03/11/1992 | CA2091257A1 Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonists activity |
03/10/1992 | CA1297021C Therapeutic agent for the treatment of peptic ulcer disease |
03/04/1992 | EP0472663A1 Method of treatment of hepatitis |
03/03/1992 | US5093318 Immunostimulating guanosine derivatives and their pharmaceutical compositions |
03/03/1992 | CA1296726C 9-hydroxyalkoxyguanines |
02/25/1992 | US5091519 Nucleotide compositions with linking groups |
02/25/1992 | US5091432 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use |
02/25/1992 | US5091431 Phosphodiesterase inhibitors |
02/20/1992 | WO1992002516A1 Process for producing 2',3'-dideoxy-2',3'-didehydronucleoside |